← Mechanisms of action
Human papillomavirus
ORGANISMHuman papillomavirus
Drugs acting on this target (96)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| 11-valent recombinant human papilloma virus vaccine | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| 15-valent recombinant human papillomavirus vaccine | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| aavlp-hpv | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ad-e6e7 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ad26.hpv16 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ad26.hpv18 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| attenuated live listeria encoding hpv 16 e7 vaccine | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| bls-ilb-e710c | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| bnt113 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| bvac-c | Immunity, active | experimental | Biological | Human papillomavirus immunity, active |
| chadox1-hpv | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| dpx-e7 vaccine | Immunity, active | experimental | Biological | Human papillomavirus immunity, active |
| e7 peptide | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| gamlpv | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| gsk1674330a | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| gsk568893a | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| gtl001 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| gx-188e | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hb-201 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hb-202 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hespecta | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hpv 16/18 vaccine (Cervarix) | Immunity, active | approved | Vaccine | Human papillomavirus immunity, active |
| hpv-t | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hpv16 ct-dna | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hpv16 e7 peptide-pulsed autologous dcs | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hpv16 rg1 vlp vaccine | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| hpvdc | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| human papillomavirus 16 e7 peptide | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| human papillomavirus 16 monovalent | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) | Immunity, active | approved | Vaccine | Human papillomavirus immunity, active |
| human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) | Immunity, active | approved | Vaccine | Human papillomavirus immunity, active |
| ibrx-042 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ino-3106 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ino-3107 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ino-3112 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| isa 101 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| liposomal hpv-16 e6/e7 multipeptide vaccine pds0101 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| mva-hpv | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| nbp615 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| nwrd08 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| octavalent hpv vaccine | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| panhpvax | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pbi-11 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pds0101 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pepcan | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pev-001 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pngvl4a-sig/e7 | Immunity, active | experimental | Biological | Human papillomavirus immunity, active |
| prgn-2009 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| procervix | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pvx-2 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| pvx7 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| recombinant 14-valent human papillomavirus | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| recombinant human papillomavirus virus type 6/11 bivalent vaccine | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| ro5217790 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| sct1000 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| sgn-00101 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| sqz-aac-hpv | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| sqz-eapc-hpv | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| synthetic human papillomavirus 16 e6 peptide | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| talen | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| tetravalent recombinant human papilloma virus vaccine (6,11,16,18 type) (hansenula polymorpha) | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| tg4001 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| v502 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| v504 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| v505 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| v540b | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| vb10.16 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| Verpasep | Immunity, active | experimental | Biological | Human papillomavirus immunity, active |
| vgx-3100 | Immunity, active | experimental | Vaccine | Human papillomavirus immunity, active |
| zopapogene imadenovec (Papzimeos) | Immunity, active | approved | Vaccine | Human papillomavirus immunity, active |
| cd8 reduced peripheral blood cells taken from related donors vaccinated against hpv16 | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| crte7a2-01 tcr-t cell | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| e6 tcr | Immunity, passive | experimental | Gene therapy | Human papillomavirus immunity, passive |
| e7 tcr transduced pbl cells | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| hpv e6-specific T cells | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| hpv e6-specific tcr-t cell with anti-pd1 auto-secreted element | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| hpv specific t cells | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| hryz-t101 | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| kite-439 | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| rtx-321 | Immunity, passive | experimental | Vaccine | Human papillomavirus immunity, passive |
| scg142 tcr-t cells | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| sqz-pbmc-hpv | Immunity, passive | experimental | Cell therapy | Human papillomavirus immunity, passive |
| abi-1968 | Inhibitor | experimental | Small molecule | Human papillomavirus inhibitor |
| abi-2280 | Inhibitor | experimental | Small molecule | Human papillomavirus inhibitor |
| ap611074 | Inhibitor | experimental | Small molecule | Human papillomavirus inhibitor |
| autologous hpv6 e6-and e7-derived peptide-loaded dendritic cell | Inhibitor | experimental | Cell therapy | Human papillomavirus inhibitor |
| av2-dm | Inhibitor | experimental | Small molecule | Human papillomavirus inhibitor |
| cue-101 | Inhibitor | experimental | Recombinant protein | Human papillomavirus inhibitor |
| HPV16-E7-T512 | Inhibitor | experimental | Biological | Human papillomavirus inhibitor |
| pf-06940434 | Inhibitor | experimental | Recombinant protein | Human papillomavirus inhibitor |
| TALEN-T27 | Inhibitor | experimental | Recombinant protein | Human papillomavirus inhibitor |
| tgn-s11 | Inhibitor | experimental | Small molecule | Human papillomavirus inhibitor |
| zfn-603 | Inhibitor | experimental | Recombinant protein | Human papillomavirus inhibitor |
| zfn-758 | Inhibitor | experimental | Recombinant protein | Human papillomavirus inhibitor |
| ilb-202 | Supplementation | experimental | Biological | Human papillomavirus supplementation |
| flubhpve6e7 | Unclear | experimental | Vaccine | Human papillomavirus unclear |